PARAMETRIC PORTFOLIO ASSOCIATES LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q1 2022$1,958,000
-20.0%
45,261
-7.4%
0.00%0.0%
Q4 2021$2,448,000
-38.6%
48,859
-22.1%
0.00%
-50.0%
Q3 2021$3,989,000
-8.4%
62,685
+3.5%
0.00%0.0%
Q2 2021$4,357,000
+23.5%
60,545
+26.5%
0.00%0.0%
Q1 2021$3,529,000
+33.2%
47,845
+32.6%
0.00%0.0%
Q4 2020$2,649,000
+226.2%
36,078
+143.9%
0.00%
+100.0%
Q3 2020$812,000
-69.7%
14,795
-63.3%
0.00%
-50.0%
Q2 2020$2,683,000
+11.7%
40,356
+2.8%
0.00%0.0%
Q1 2020$2,402,000
-43.3%
39,241
-18.6%
0.00%
-33.3%
Q4 2019$4,239,000
+15.9%
48,208
-0.5%
0.00%0.0%
Q3 2019$3,657,000
+19.0%
48,472
+34.8%
0.00%0.0%
Q2 2019$3,072,000
+0.9%
35,967
+27.7%
0.00%0.0%
Q1 2019$3,045,000
+42.0%
28,174
+11.2%
0.00%
+50.0%
Q4 2018$2,145,000
-50.1%
25,340
-42.0%
0.00%
-50.0%
Q3 2018$4,296,000
-16.5%
43,706
-1.7%
0.00%
-20.0%
Q2 2018$5,142,000
+12.1%
44,445
-4.3%
0.01%0.0%
Q1 2018$4,588,000
-45.6%
46,461
-42.3%
0.01%
-37.5%
Q4 2017$8,427,000
-20.4%
80,476
-14.4%
0.01%
-27.3%
Q3 2017$10,590,000
-9.8%
93,979
-10.3%
0.01%
-21.4%
Q2 2017$11,746,000
-2.3%
104,818
+1.7%
0.01%
-22.2%
Q1 2017$12,025,000
+27.3%
103,110
+14.9%
0.02%
+38.5%
Q4 2016$9,443,000
+508.8%
89,702
+539.3%
0.01%
+550.0%
Q3 2016$1,551,000
-45.6%
14,032
-28.3%
0.00%
-50.0%
Q2 2016$2,850,000
+58.2%
19,574
+55.7%
0.00%
+33.3%
Q1 2016$1,801,000
+92.0%
12,570
+107.0%
0.00%
+50.0%
Q4 2015$938,0006,0710.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders